Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Zotarolimus manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zotarolimus, including repackagers and relabelers. The FDA regulates Zotarolimus manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zotarolimus API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Zotarolimus supplier is an individual or a company that provides Zotarolimus active pharmaceutical ingredient (API) or Zotarolimus finished formulations upon request. The Zotarolimus suppliers may include Zotarolimus API manufacturers, exporters, distributors and traders.
click here to find a list of Zotarolimus suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Zotarolimus DMF (Drug Master File) is a document detailing the whole manufacturing process of Zotarolimus active pharmaceutical ingredient (API) in detail. Different forms of Zotarolimus DMFs exist exist since differing nations have different regulations, such as Zotarolimus USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Zotarolimus DMF submitted to regulatory agencies in the US is known as a USDMF. Zotarolimus USDMF includes data on Zotarolimus's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Zotarolimus USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Zotarolimus suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Zotarolimus Drug Master File in Japan (Zotarolimus JDMF) empowers Zotarolimus API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Zotarolimus JDMF during the approval evaluation for pharmaceutical products. At the time of Zotarolimus JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Zotarolimus suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zotarolimus as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zotarolimus API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zotarolimus as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zotarolimus and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zotarolimus NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zotarolimus suppliers with NDC on PharmaCompass.
Zotarolimus Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zotarolimus GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zotarolimus GMP manufacturer or Zotarolimus GMP API supplier for your needs.
A Zotarolimus CoA (Certificate of Analysis) is a formal document that attests to Zotarolimus's compliance with Zotarolimus specifications and serves as a tool for batch-level quality control.
Zotarolimus CoA mostly includes findings from lab analyses of a specific batch. For each Zotarolimus CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zotarolimus may be tested according to a variety of international standards, such as European Pharmacopoeia (Zotarolimus EP), Zotarolimus JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zotarolimus USP).
LOOKING FOR A SUPPLIER?
